​​​
  1. Dr Reddy’s Laboratories gets EIR for Srikakulam plant

Dr Reddy’s Laboratories gets EIR for Srikakulam plant

Without going into the content of the EIR, said the USFDA has maintained official action indicated status at its plant.

By: | Published: February 27, 2018 2:01 AM
DRL, Dr Reddy's Laboratories, EIR, Srikakulam plant Dr Reddy’s Laboratories has received the establishment inspection report (EIR) from the drug regulator USFDA for its Srikakulam plant. (Reuters)

Dr Reddy’s Laboratories has received the establishment inspection report (EIR) from the drug regulator USFDA for its Srikakulam plant. The drug regulator has sought more details post its inspection of the plant. Without going into the content of the EIR, said the USFDA has maintained official action indicated status at its plant. “The FDA has asked us for more details. We are providing those details and continuing to engage with the FDA for resolution of pending issues,” DRL said in a filing.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

  1. No Comments.

Go to Top